You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

Actavis Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for ACTAVIS, and what generic and branded alternatives to ACTAVIS drugs are available?

ACTAVIS has three hundred and twenty-five approved drugs.

There are twenty tentative approvals on ACTAVIS drugs.

Drugs and US Patents for Actavis

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Elizabeth BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE bisoprolol fumarate; hydrochlorothiazide TABLET;ORAL 075672-003 Sep 25, 2000 DISCN No No ⤷  Sign Up ⤷  Sign Up
Actavis Labs Fl Inc FOSINOPRIL SODIUM fosinopril sodium TABLET;ORAL 076620-002 Oct 15, 2004 DISCN No No ⤷  Sign Up ⤷  Sign Up
Actavis Mid Atlantic VALNAC betamethasone valerate CREAM;TOPICAL 070050-001 Oct 10, 1984 AB RX No No ⤷  Sign Up ⤷  Sign Up
Actavis Elizabeth CLONAZEPAM clonazepam TABLET;ORAL 074869-001 Oct 31, 1996 AB RX No No ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for ACTAVIS drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.